Alzheimer's Disease

Newly FDA Approved Alzheimer’s Biomarkers Testing: How to Implement Such Tests in Core Laboratory?

These activities are designed to help pathologists and laboratory professionals gain an understanding of plasma testing for markers such as Abeta40/42, P-tau181, and P-tau217 which are rapidly appearing in the commercial space and how healthcare providers have begun incorporating these tests into routine neurology practice. This webcast and podcast will help participants understand the advantages and limitations of these assays as well as their potential application when a physician is evaluating a patient for AD.

Faculty:

Amitava Dasgupta, Ph.D.
Kelsey Woodard, MLS (ASCP)

Webcast

Inside the Lab: Newly FDA Approved Alzheimer’s Biomarkers Testing: How to Implement Such Tests in Core Laboratory

Watch On YouTube

Claim Credit Download the Slides (pdf)

Podcast

Inside the Lab: Newly FDA Approved Alzheimer’s Biomarkers Testing: How to Implement Such Tests in Core Laboratory

Listen Now

Claim Credit

First Name *
Last Name *
Email *
Customer ID

Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id